[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Interleukin 7 Receptor Subunit Alpha Market Report 2017

January 2018 | 101 pages | ID: U3BC5860088EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Interleukin 7 Receptor Subunit Alpha market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Interleukin 7 Receptor Subunit Alpha in these regions, from 2012 to 2022 (forecast).
United States Interleukin 7 Receptor Subunit Alpha market competition by top manufacturers/players, with Interleukin 7 Receptor Subunit Alpha sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Genexine Inc
  • GlaxoSmithKline Plc
  • OSE Immunotherapeutics
  • Pfizer Inc
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • CYT-107
  • GSK-2618960
  • GX-I7
  • OSE-127
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • High-Grade Glioma
  • Multiple Sclerosis
  • Spesis
  • Solid Tumor
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Interleukin 7 Receptor Subunit Alpha Market Report 2017

1 INTERLEUKIN 7 RECEPTOR SUBUNIT ALPHA OVERVIEW

1.1 Product Overview and Scope of Interleukin 7 Receptor Subunit Alpha
1.2 Classification of Interleukin 7 Receptor Subunit Alpha by Product Category
  1.2.1 United States Interleukin 7 Receptor Subunit Alpha Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Interleukin 7 Receptor Subunit Alpha Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 CYT-107
  1.2.4 GSK-2618960
  1.2.5 GX-I7
  1.2.6 OSE-127
  1.2.7 Others
1.3 United States Interleukin 7 Receptor Subunit Alpha Market by Application/End Users
  1.3.1 United States Interleukin 7 Receptor Subunit Alpha Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 High-Grade Glioma
  1.3.3 Multiple Sclerosis
  1.3.4 Spesis
  1.3.5 Solid Tumor
  1.3.6 Others
1.4 United States Interleukin 7 Receptor Subunit Alpha Market by Region
  1.4.1 United States Interleukin 7 Receptor Subunit Alpha Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Interleukin 7 Receptor Subunit Alpha Status and Prospect (2012-2022)
  1.4.3 Southwest Interleukin 7 Receptor Subunit Alpha Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Interleukin 7 Receptor Subunit Alpha Status and Prospect (2012-2022)
  1.4.5 New England Interleukin 7 Receptor Subunit Alpha Status and Prospect (2012-2022)
  1.4.6 The South Interleukin 7 Receptor Subunit Alpha Status and Prospect (2012-2022)
  1.4.7 The Midwest Interleukin 7 Receptor Subunit Alpha Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Interleukin 7 Receptor Subunit Alpha (2012-2022)
  1.5.1 United States Interleukin 7 Receptor Subunit Alpha Sales and Growth Rate (2012-2022)
  1.5.2 United States Interleukin 7 Receptor Subunit Alpha Revenue and Growth Rate (2012-2022)

2 UNITED STATES INTERLEUKIN 7 RECEPTOR SUBUNIT ALPHA MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Interleukin 7 Receptor Subunit Alpha Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Interleukin 7 Receptor Subunit Alpha Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Interleukin 7 Receptor Subunit Alpha Average Price by Players/Suppliers (2012-2017)
2.4 United States Interleukin 7 Receptor Subunit Alpha Market Competitive Situation and Trends
  2.4.1 United States Interleukin 7 Receptor Subunit Alpha Market Concentration Rate
  2.4.2 United States Interleukin 7 Receptor Subunit Alpha Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Interleukin 7 Receptor Subunit Alpha Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES INTERLEUKIN 7 RECEPTOR SUBUNIT ALPHA SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Interleukin 7 Receptor Subunit Alpha Sales and Market Share by Region (2012-2017)
3.2 United States Interleukin 7 Receptor Subunit Alpha Revenue and Market Share by Region (2012-2017)
3.3 United States Interleukin 7 Receptor Subunit Alpha Price by Region (2012-2017)

4 UNITED STATES INTERLEUKIN 7 RECEPTOR SUBUNIT ALPHA SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Interleukin 7 Receptor Subunit Alpha Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Interleukin 7 Receptor Subunit Alpha Revenue and Market Share by Type (2012-2017)
4.3 United States Interleukin 7 Receptor Subunit Alpha Price by Type (2012-2017)
4.4 United States Interleukin 7 Receptor Subunit Alpha Sales Growth Rate by Type (2012-2017)

5 UNITED STATES INTERLEUKIN 7 RECEPTOR SUBUNIT ALPHA SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Interleukin 7 Receptor Subunit Alpha Sales and Market Share by Application (2012-2017)
5.2 United States Interleukin 7 Receptor Subunit Alpha Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES INTERLEUKIN 7 RECEPTOR SUBUNIT ALPHA PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Genexine Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Interleukin 7 Receptor Subunit Alpha Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Genexine Inc Interleukin 7 Receptor Subunit Alpha Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GlaxoSmithKline Plc
  6.2.2 Interleukin 7 Receptor Subunit Alpha Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GlaxoSmithKline Plc Interleukin 7 Receptor Subunit Alpha Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 OSE Immunotherapeutics
  6.3.2 Interleukin 7 Receptor Subunit Alpha Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 OSE Immunotherapeutics Interleukin 7 Receptor Subunit Alpha Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer Inc
  6.4.2 Interleukin 7 Receptor Subunit Alpha Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Inc Interleukin 7 Receptor Subunit Alpha Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview

7 INTERLEUKIN 7 RECEPTOR SUBUNIT ALPHA MANUFACTURING COST ANALYSIS

7.1 Interleukin 7 Receptor Subunit Alpha Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Interleukin 7 Receptor Subunit Alpha

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Interleukin 7 Receptor Subunit Alpha Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Interleukin 7 Receptor Subunit Alpha Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES INTERLEUKIN 7 RECEPTOR SUBUNIT ALPHA MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Interleukin 7 Receptor Subunit Alpha Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Interleukin 7 Receptor Subunit Alpha Sales Volume Forecast by Type (2017-2022)
11.3 United States Interleukin 7 Receptor Subunit Alpha Sales Volume Forecast by Application (2017-2022)
11.4 United States Interleukin 7 Receptor Subunit Alpha Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Interleukin 7 Receptor Subunit Alpha
Figure United States Interleukin 7 Receptor Subunit Alpha Market Size (K Pcs) by Type (2012-2022)
Figure United States Interleukin 7 Receptor Subunit Alpha Sales Volume Market Share by Type (Product Category) in 2016
Figure CYT-107 Product Picture
Figure GSK-2618960 Product Picture
Figure GX-I7 Product Picture
Figure OSE-127 Product Picture
Figure Others Product Picture
Figure United States Interleukin 7 Receptor Subunit Alpha Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Interleukin 7 Receptor Subunit Alpha by Application in 2016
Figure High-Grade Glioma Examples
Table Key Downstream Customer in High-Grade Glioma
Figure Multiple Sclerosis Examples
Table Key Downstream Customer in Multiple Sclerosis
Figure Spesis Examples
Table Key Downstream Customer in Spesis
Figure Solid Tumor Examples
Table Key Downstream Customer in Solid Tumor
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Interleukin 7 Receptor Subunit Alpha Market Size (Million USD) by Region (2012-2022)
Figure The West Interleukin 7 Receptor Subunit Alpha Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Interleukin 7 Receptor Subunit Alpha Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Interleukin 7 Receptor Subunit Alpha Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Interleukin 7 Receptor Subunit Alpha Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Interleukin 7 Receptor Subunit Alpha Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Interleukin 7 Receptor Subunit Alpha Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Interleukin 7 Receptor Subunit Alpha Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Interleukin 7 Receptor Subunit Alpha Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Interleukin 7 Receptor Subunit Alpha Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Interleukin 7 Receptor Subunit Alpha Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Interleukin 7 Receptor Subunit Alpha Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Interleukin 7 Receptor Subunit Alpha Sales Share by Players/Suppliers
Figure 2017 United States Interleukin 7 Receptor Subunit Alpha Sales Share by Players/Suppliers
Figure United States Interleukin 7 Receptor Subunit Alpha Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Interleukin 7 Receptor Subunit Alpha Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Interleukin 7 Receptor Subunit Alpha Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Interleukin 7 Receptor Subunit Alpha Revenue Share by Players/Suppliers
Figure 2017 United States Interleukin 7 Receptor Subunit Alpha Revenue Share by Players/Suppliers
Table United States Market Interleukin 7 Receptor Subunit Alpha Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Interleukin 7 Receptor Subunit Alpha Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Interleukin 7 Receptor Subunit Alpha Market Share of Top 3 Players/Suppliers
Figure United States Interleukin 7 Receptor Subunit Alpha Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Interleukin 7 Receptor Subunit Alpha Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Interleukin 7 Receptor Subunit Alpha Product Category
Table United States Interleukin 7 Receptor Subunit Alpha Sales (K Pcs) by Region (2012-2017)
Table United States Interleukin 7 Receptor Subunit Alpha Sales Share by Region (2012-2017)
Figure United States Interleukin 7 Receptor Subunit Alpha Sales Share by Region (2012-2017)
Figure United States Interleukin 7 Receptor Subunit Alpha Sales Market Share by Region in 2016
Table United States Interleukin 7 Receptor Subunit Alpha Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Interleukin 7 Receptor Subunit Alpha Revenue Share by Region (2012-2017)
Figure United States Interleukin 7 Receptor Subunit Alpha Revenue Market Share by Region (2012-2017)
Figure United States Interleukin 7 Receptor Subunit Alpha Revenue Market Share by Region in 2016
Table United States Interleukin 7 Receptor Subunit Alpha Price (USD/Pcs) by Region (2012-2017)
Table United States Interleukin 7 Receptor Subunit Alpha Sales (K Pcs) by Type (2012-2017)
Table United States Interleukin 7 Receptor Subunit Alpha Sales Share by Type (2012-2017)
Figure United States Interleukin 7 Receptor Subunit Alpha Sales Share by Type (2012-2017)
Figure United States Interleukin 7 Receptor Subunit Alpha Sales Market Share by Type in 2016
Table United States Interleukin 7 Receptor Subunit Alpha Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Interleukin 7 Receptor Subunit Alpha Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Interleukin 7 Receptor Subunit Alpha by Type (2012-2017)
Figure Revenue Market Share of Interleukin 7 Receptor Subunit Alpha by Type in 2016
Table United States Interleukin 7 Receptor Subunit Alpha Price (USD/Pcs) by Types (2012-2017)
Figure United States Interleukin 7 Receptor Subunit Alpha Sales Growth Rate by Type (2012-2017)
Table United States Interleukin 7 Receptor Subunit Alpha Sales (K Pcs) by Application (2012-2017)
Table United States Interleukin 7 Receptor Subunit Alpha Sales Market Share by Application (2012-2017)
Figure United States Interleukin 7 Receptor Subunit Alpha Sales Market Share by Application (2012-2017)
Figure United States Interleukin 7 Receptor Subunit Alpha Sales Market Share by Application in 2016
Table United States Interleukin 7 Receptor Subunit Alpha Sales Growth Rate by Application (2012-2017)
Figure United States Interleukin 7 Receptor Subunit Alpha Sales Growth Rate by Application (2012-2017)
Table Genexine Inc Basic Information List
Table Genexine Inc Interleukin 7 Receptor Subunit Alpha Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Genexine Inc Interleukin 7 Receptor Subunit Alpha Sales Growth Rate (2012-2017)
Figure Genexine Inc Interleukin 7 Receptor Subunit Alpha Sales Market Share in United States (2012-2017)
Figure Genexine Inc Interleukin 7 Receptor Subunit Alpha Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Plc Basic Information List
Table GlaxoSmithKline Plc Interleukin 7 Receptor Subunit Alpha Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc Interleukin 7 Receptor Subunit Alpha Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc Interleukin 7 Receptor Subunit Alpha Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Plc Interleukin 7 Receptor Subunit Alpha Revenue Market Share in United States (2012-2017)
Table OSE Immunotherapeutics Basic Information List
Table OSE Immunotherapeutics Interleukin 7 Receptor Subunit Alpha Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure OSE Immunotherapeutics Interleukin 7 Receptor Subunit Alpha Sales Growth Rate (2012-2017)
Figure OSE Immunotherapeutics Interleukin 7 Receptor Subunit Alpha Sales Market Share in United States (2012-2017)
Figure OSE Immunotherapeutics Interleukin 7 Receptor Subunit Alpha Revenue Market Share in United States (2012-2017)
Table Pfizer Inc Basic Information List
Table Pfizer Inc Interleukin 7 Receptor Subunit Alpha Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Inc Interleukin 7 Receptor Subunit Alpha Sales Growth Rate (2012-2017)
Figure Pfizer Inc Interleukin 7 Receptor Subunit Alpha Sales Market Share in United States (2012-2017)
Figure Pfizer Inc Interleukin 7 Receptor Subunit Alpha Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Interleukin 7 Receptor Subunit Alpha
Figure Manufacturing Process Analysis of Interleukin 7 Receptor Subunit Alpha
Figure Interleukin 7 Receptor Subunit Alpha Industrial Chain Analysis
Table Raw Materials Sources of Interleukin 7 Receptor Subunit Alpha Major Players/Suppliers in 2016
Table Major Buyers of Interleukin 7 Receptor Subunit Alpha
Table Distributors/Traders List
Figure United States Interleukin 7 Receptor Subunit Alpha Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Interleukin 7 Receptor Subunit Alpha Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Interleukin 7 Receptor Subunit Alpha Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Interleukin 7 Receptor Subunit Alpha Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Interleukin 7 Receptor Subunit Alpha Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Interleukin 7 Receptor Subunit Alpha Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Interleukin 7 Receptor Subunit Alpha Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Interleukin 7 Receptor Subunit Alpha Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Interleukin 7 Receptor Subunit Alpha Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Interleukin 7 Receptor Subunit Alpha Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Interleukin 7 Receptor Subunit Alpha Sales Volume Share Forecast by Region (2017-2022)
Figure United States Interleukin 7 Receptor Subunit Alpha Sales Volume Share Forecast by Region (2017-2022)
Figure United States Interleukin 7 Receptor Subunit Alpha Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications